Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

The prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to shift the market?

NVO's first-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, especially ...

The active ingredient in Rybelsus is semaglutide. (An active ingredient is what makes a drug work.) The drug comes as a tablet that you swallow. Keep reading to learn about the common, mild ...

Eli Lilly misses first-quarter estimates for earnings but beats the same for sales. Mounjaro and Zepbound sales beat ...

Rybelsus (semaglutide) and Ozempic (semaglutide) are prescription drugs used to treat type 2 diabetes. Rybelsus comes as an oral tablet, while Ozempic comes as an injectable liquid solution.

The global Oral Proteins & Peptides Market , valued at US$7.35 billion in 2024, is forecasted to grow at a robust CAGR of ...

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.